Eli Lily Tries to Extend Exclusivity on Cancer Drug
- Sunday, 25 August 2013
- Big Law
Facing the natural expiration of the patent on its highly profitable lung-cancer treatment Alimta, Eli Lily this month went to trial to defend a follow-on patent for the treatment.
Read more...Most Read
-
-
Apr 07 2013
-
Written by PLP News
In a sensational case that has reportedly “grabbed the attention…
-
-
-
Mar 31 2013
-
Written by PLP News
A DLA Piper associate’s e-mail stating “that bill shall know…
-
-
-
Jan 26 2014
-
Written by PLP News
A 55-year-old attorney at White & Case, who recently filed…
-
-
-
Jun 15 2014
-
Written by Tami Kamin Meyer
More than 1.2 million applications, or “apps,” are available at…
-